- Home
- ACON vs CMND Comparison
ACON vs CMND Comparison
Compare ACON & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACON
- CMND
- Stock Information
- Founded
- ACON 2008
- CMND 2017
- Country
- ACON United States
- CMND Canada
- Employees
- ACON N/A
- CMND N/A
- Industry
- ACON Retail: Computer Software & Peripheral Equipment
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- ACON Technology
- CMND Health Care
- Exchange
- ACON Nasdaq
- CMND Nasdaq
- Market Cap
- ACON 4.5M
- CMND 5.3M
- IPO Year
- ACON 2022
- CMND N/A
- Fundamental
- Price
- ACON $7.47
- CMND $1.03
- Analyst Decision
- ACON Buy
- CMND
- Analyst Count
- ACON 2
- CMND 0
- Target Price
- ACON $481.00
- CMND N/A
- AVG Volume (30 Days)
- ACON 13.2K
- CMND 2.5M
- Earning Date
- ACON 08-13-2025
- CMND 09-15-2025
- Dividend Yield
- ACON N/A
- CMND N/A
- EPS Growth
- ACON N/A
- CMND N/A
- EPS
- ACON N/A
- CMND N/A
- Revenue
- ACON $54,601.00
- CMND N/A
- Revenue This Year
- ACON $145.39
- CMND N/A
- Revenue Next Year
- ACON $145.45
- CMND N/A
- P/E Ratio
- ACON N/A
- CMND N/A
- Revenue Growth
- ACON N/A
- CMND N/A
- 52 Week Low
- ACON $6.20
- CMND $0.80
- 52 Week High
- ACON $3,499.51
- CMND $2.18
- Technical
- Relative Strength Index (RSI)
- ACON 49.34
- CMND 53.10
- Support Level
- ACON $7.12
- CMND $1.00
- Resistance Level
- ACON $7.60
- CMND $1.25
- Average True Range (ATR)
- ACON 0.35
- CMND 0.08
- MACD
- ACON 0.04
- CMND 0.01
- Stochastic Oscillator
- ACON 55.72
- CMND 30.82
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.